DEFA14A: CalciMedica to Hold Annual Stockholders Meeting, Proposes Director Elections and Equity Incentive Plan Amendment
Proxy Statement
CalciMedica, Inc. will hold its annual stockholders meeting on June 24, 2025, to elect directors, ratify the appointment of its accounting firm, and approve an amendment to its equity incentive plan.
Summary
- CalciMedica, Inc. is holding its annual meeting of stockholders on June 24, 2025.
- The meeting will include the election of three Class II directors to serve until the 2028 annual meeting.
- The nominees are Rachel Leheny, Ph.D., Eric W. Roberts, and Frederic Guerard, Pharm.D.
- Stockholders will also vote to ratify the appointment of Moss Adams LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- An amendment to the CalciMedica, Inc. Amended 2023 Equity Incentive Plan will be voted on, which includes increasing the number of shares authorized for issuance by 600,000 shares.
- The board of directors recommends voting for the director nominees and Proposals 2 and 3.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, indicating normal corporate operations. The board's recommendations suggest a positive outlook, but the document itself is neutral.
Positives
- The board recommends voting for all director nominees and the proposals, suggesting confidence in the company's direction.
Future Outlook
The document outlines upcoming corporate governance actions for the next fiscal year.
Industry Context
This is a standard proxy statement related to corporate governance matters, which is a routine part of operating a public company.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Election | Election of three Class II directors: Rachel Leheny, Ph.D., Eric W. Roberts, and Frederic Guerard, Pharm.D. | June 24, 2025 | Will determine the composition of the board of directors. |
| Accounting Firm Ratification | Ratification of Moss Adams LLP as the independent registered public accounting firm. | December 31, 2025 | Ensures independent auditing of the company's financial statements. |
| Equity Incentive Plan Amendment | Amendment to the CalciMedica, Inc. Amended 2023 Equity Incentive Plan to increase the number of shares authorized for issuance by 600,000 shares. | June 24, 2025 | Affects the company's ability to grant stock options and other equity-based compensation. |
Stakeholder Impact
- Shareholders will vote on key governance matters.
- Employees may be affected by changes to the equity incentive plan.
- The selection of the accounting firm impacts the credibility of financial reporting.
Next Steps
- Stockholders need to review the proxy materials and vote on the proposals.
- The company will proceed with the annual meeting on June 24, 2025.
Key Dates
| Date | Description |
|---|---|
| April 28, 2025 | Stockholders of Record date |
| June 13, 2025 | Deadline to request paper copies of proxy materials |
| June 24, 2025 | Annual Meeting of Stockholders |
| December 31, 2025 | Fiscal year end for which Moss Adams LLP is proposed as the accounting firm |
| 2028 | Year of the annual meeting following the 2025 annual meeting for which the Class II directors will serve |
Keywords
Annual Meeting, Stockholders, Proxy Statement, Director Election, Equity Incentive Plan, Moss Adams, CalciMedica
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.